Human chimeric antibody specific for the ganglioside GD3
US6437098B1 · kind B1 · utility
31Cited by
1References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 5, 1999 |
| Grant date | Aug 20, 2002 |
| Priority date | — |
| Expiry date | Jan 5, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A humanized chimera antibody, a pharmaceutical composition comprising a humanized chimera antibody and a pharmaceutically acceptable carrier, and a method of treating cancer which comprises administering to a patient a pharmaceutically acceptable amount of the humanized chimera antibody, are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.